Alpha 2.0
Login Register
» Articles » PMID: 36537705

Chronic Actinic Dermatitis Successfully Treated with Methotrexate and Dupilumab

Overview
Journal Photodermatol Photoimmunol Photomed
Specialties Allergy & Immunology
Dermatology
Date 2022 Dec 20
PMID 36537705
Authors
Orla McFeely
Claire Doyle
Marta Costa Blasco
Paula Beatty
Lisa Murphy
Sarah OMahony
Madonna Andrawis
Asad Salim
Affiliations
Soon will be listed here.
Citing Articles

Long-term Remission of Severe and Refractory Chronic Actinic Dermatosis with Dupilumab: A Case Report with Review of the Literature.

Vanhaecke C, Viguier M Acta Derm Venereol. 2024; 104:adv40453.

PMID: 39175450 PMC: 11358845. DOI: 10.2340/actadv.v104.40453.

The Effectiveness and Safety of Dupilumab for the Treatment of Recalcitrant Chronic Actinic Dermatitis: A Case Series.

Chen J, Yu N, Wu W, Ou S, Chen Q, Zhu H Clin Cosmet Investig Dermatol. 2023; 16:2357-2363.

PMID: 37663886 PMC: 10474848. DOI: 10.2147/CCID.S422683.

Dupilumab in Inflammatory Skin Diseases: A Systematic Review.

Olbrich H, Sadik C, Ludwig R, Thaci D, Boch K Biomolecules. 2023; 13(4).

PMID: 37189381 PMC: 10136243. DOI: 10.3390/biom13040634.